Page last updated: 2024-08-22

gadolinium and methylene blue

gadolinium has been researched along with methylene blue in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brossmann, J; Goodwin, DW; Resnick, DL; Salonen, DC; Trudell, DJ; Yu, JS	1
Birdwell, RL; Black, JW; Block, WF; Daniel, BL; Glover, GH; Herfkens, RJ; Ikeda, DM; Jeffrey, SS; Sawyer-Glover, AM	1
Beguin, C; Carton, H; D'Hooghe, MB; Dooms, G; Lissoir, F; Sindic, CJ; van de Wyngaert, FA	1
Mamba, G; Mbianda, XY; Mishra, AK	1

Trials

1 trial(s) available for gadolinium and methylene blue

Article	Year
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. Acta neurologica Belgica, 2001, Volume: 101, Issue:4 Topics: Adult; Alopecia; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylene Blue; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Nausea; Patient Dropouts; Phlebitis; Pulmonary Embolism; Pyrrolidines; Recurrence; Severity of Illness Index; Treatment Outcome; Vomiting	2001

Article

Year

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.

Acta neurologica Belgica, 2001, Volume: 101, Issue:4

Topics: Adult; Alopecia; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylene Blue; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Nausea; Patient Dropouts; Phlebitis; Pulmonary Embolism; Pyrrolidines; Recurrence; Severity of Illness Index; Treatment Outcome; Vomiting

2001

Other Studies

3 other study(ies) available for gadolinium and methylene blue

Article	Year
Plantar compartments of the foot: MR appearance in cadavers and diabetic patients. Radiology, 1995, Volume: 196, Issue:3 Topics: Cadaver; Contrast Media; Copper; Copper Sulfate; Diabetic Foot; Drug Combinations; Exudates and Transudates; Fascia; Foot; Gadolinium; Gadolinium DTPA; Gelatin; Humans; Iothalamate Meglumine; Magnetic Resonance Imaging; Meglumine; Metatarsophalangeal Joint; Metatarsus; Methylene Blue; Muscle, Skeletal; Organometallic Compounds; Pentetic Acid; Soft Tissue Infections; Tendons	1995
Breast lesion localization: a freehand, interactive MR imaging-guided technique. Radiology, 1998, Volume: 207, Issue:2 Topics: Adult; Aged; Biopsy, Needle; Breast Implants; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Contrast Media; Equipment Design; Evaluation Studies as Topic; Female; Fibroadenoma; Fibrocystic Breast Disease; Follow-Up Studies; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mammography; Methylene Blue; Middle Aged; Needles; Organometallic Compounds; Pressure; Prone Position; Radiology, Interventional; Stereotaxic Techniques; Thorax; Ultrasonography, Mammary	1998
Gadolinium nanoparticle-decorated multiwalled carbon nanotube/titania nanocomposites for degradation of methylene blue in water under simulated solar light. Environmental science and pollution research international, 2014, Volume: 21, Issue:8 Topics: Catalysis; Gadolinium; Light; Methylene Blue; Models, Chemical; Nanoparticles; Nanotubes, Carbon; Photochemical Processes; Titanium; Water Pollutants, Chemical	2014